Intraoperative concentrations of ofloxacin in serum, bile fluid, and gallbladder wall tissue

To evaluate concentrations of ofloxacin in serum, bile fluid, and gallbladder wall tissue after intravenous administration, patients greater than or equal to 16 years old diagnosed with acute cholecystitis were randomly assigned to receive ofloxacin (400 mg) intravenously every 12 h or ceftazidime (2 g) intravenously every 8 h. Doses of each regimen were given preoperatively. Serum, bile fluid, and gallbladder wall tissue samples of consecutive patients in the ofloxacin group were obtained intraoperatively. The samples were frozen at -70 degrees C until analyzed by high-pressure liquid chromatography. Twenty-three patients (6 males and 17 females) were evaluated. The mean (+/- the standard deviation) ofloxacin concentrations in serum, bile fluid, and gallbladder wall tissue were 2.9 +/- 2.4 and 6.0 +/- 7.9 micrograms/ml and 3.1 +/- 2.9 micrograms/g, respectively. The mean number of doses each patient received before surgery was 5.3 +/- 3.0, and the mean delta time (time elapsed between last antibiotic administration and when intraoperative samples were obtained) was 9.6 +/- 7.5 h. The mean tissue-to-serum ratio was 1.2 +/- 0.5, and the mean bile-to-serum ratio was 2.3 +/- 1.4. The mean serum ofloxacin concentrations were not statistically different from the concentrations in bile (P = 0.1) and tissue (P = 0.7) at the mean delta time. The study revealed that concentrations of ofloxacin in serum, bile fluid, and gallbladder tissue after intravenous dosing were adequate against susceptible organisms found in the biliary tract.

[1]  T. Berne,et al.  Controlled comparison of cefmetazole with cefoxitin for prophylaxis in elective cholecystectomy. , 1990, Surgery, gynecology & obstetrics.

[2]  S. Flor Pharmacokinetics of ofloxacin. An overview. , 1989, The American journal of medicine.

[3]  M. Smythe,et al.  Ofloxacin: A Review , 1989, DICP : the annals of pharmacotherapy.

[4]  J. Pocidalo Use of fluoroquinolones for intracellular pathogens. , 1989, Reviews of infectious diseases.

[5]  Jerome J. Schentag Clinical Significance of Antibiotic Tissue Penetration , 1989, Clinical pharmacokinetics.

[6]  R. Wise,et al.  The pharmacokinetics of ofloxacin and a review of its tissue penetration. , 1988, The Journal of antimicrobial chemotherapy.

[7]  B. Gordts,et al.  Pharmacokinetic evaluation of ofloxacin in serum and tonsils. , 1988, The Journal of antimicrobial chemotherapy.

[8]  T. Vree,et al.  The penetration of ofloxacin into lung tissue. , 1988, The Journal of antimicrobial chemotherapy.

[9]  B. Walsh,et al.  Pharmacokinetics of ofloxacin and the effect on the faecal flora of healthy volunteers. , 1988, The Journal of antimicrobial chemotherapy.

[10]  M. Keighley Infection: prophylaxis. , 1988, British medical bulletin.

[11]  A. Javaid,et al.  Penetration of ofloxacin into bronchial secretions. , 1988, Drugs.

[12]  H. Koga High-performance liquid chromatography measurement of antimicrobial concentrations in polymorphonuclear leukocytes , 1987, Antimicrobial Agents and Chemotherapy.

[13]  G. Geelhoed,et al.  Biliary antibiotics: clinical utility in biliary surgery. , 1987, Southern medical journal.

[14]  S. Pattyn,et al.  In vitro activity of ciprofloxacin compared with those of other new fluorinated piperazinyl-substituted quinoline derivatives , 1984, Antimicrobial Agents and Chemotherapy.

[15]  R. Wise,et al.  In-vitro activity of enoxacin (CL-919), a new quinoline derivative, compared with that of other antimicrobial agents. , 1984, The Journal of antimicrobial chemotherapy.

[16]  S. Mitsuhashi,et al.  In vitro and in vivo activity of DL-8280, a new oxazine derivative , 1982, Antimicrobial Agents and Chemotherapy.

[17]  R. Beart,et al.  Elective cholecystectomy. The role of biliary bacteriology and administration of antibiotics. , 1981, Archives of surgery.

[18]  A. Gunn Antibiotics in biliary surgery , 1976, The British journal of surgery.